{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T15:16:58Z","timestamp":1780499818986,"version":"3.54.1"},"reference-count":77,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T00:00:00Z","timestamp":1666224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Qatar Biomedical Research Institute","award":["VR93"],"award-info":[{"award-number":["VR93"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Non-alcoholic fatty liver disease (NAFLD) is a common liver lesion that is untreatable with medications. Glucagon-like peptide-1 receptor (GLP-1R) agonists have recently emerged as a potential NAFLD pharmacotherapy. However, the molecular mechanisms underlying these drugs\u2019 beneficial effects are not fully understood. Using Fourier transform infrared (FTIR) spectroscopy, we sought to investigate the biochemical changes in a steatosis cell model treated or not with the GLP-1R agonist Exendin-4 (Ex-4). HepG2 cells were made steatotic with 400 \u00b5M of oleic acid and then treated with 200 nM Ex-4 in order to reduce lipid accumulation. We quantified steatosis using the Oil Red O staining method. We investigated the biochemical alterations induced by steatosis and Ex-4 treatment using Fourier transform infrared (FTIR) spectroscopy and chemometric analyses. Analysis of the Oil Red O staining showed that Ex-4 significantly reduces steatosis. This reduction was confirmed by FTIR analysis, as the phospholipid band (C=O) at 1740 cm\u22121 in Ex-4 treated cells is significantly decreased compared to steatotic cells. The principal component analysis score plots for both the lipid and protein regions showed that the untreated and Ex-4-treated samples, while still separated, are clustered close to each other, far from the steatotic cells. The biochemical and structural changes induced by OA-induced lipotoxicity are at least partially reversed upon Ex-4 treatment. FTIR and chemometric analyses revealed that Ex-4 significantly reduces OA-induced lipid accumulation, and Ex-4 also restored the lipid and protein biochemical alterations caused by lipotoxicity-induced oxidative stress. In combination with chemometric analyses, FTIR spectroscopy may offer new approaches for investigating the mechanisms underpinning NAFLD.<\/jats:p>","DOI":"10.3390\/biomedicines10102652","type":"journal-article","created":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T20:35:55Z","timestamp":1666298155000},"page":"2652","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Investigation of the Effect of Exendin-4 on Oleic Acid-Induced Steatosis in HepG2 Cells Using Fourier Transform Infrared Spectroscopy"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5469-291X","authenticated-orcid":false,"given":"Olfa","family":"Khalifa","sequence":"first","affiliation":[{"name":"Diabetes Research Center, Qatar Biomedical Research Institute, Hamad Bin Khalifa University, Qatar Foundation, Doha 34110, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4737-6529","authenticated-orcid":false,"given":"Kamal","family":"H. Mroue","sequence":"additional","affiliation":[{"name":"Qatar Environment and Energy Research Institute, Hamad Bin Khalifa University (HBKU), Qatar Foundation, Doha 34110, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1779-3150","authenticated-orcid":false,"given":"Raghvendra","family":"Mall","sequence":"additional","affiliation":[{"name":"Qatar Computing Research Institute, Hamad Bin Khalifa University, Qatar Foundation, Doha 34110, Qatar"},{"name":"Department of Immunology, St. Jude Children\u2019s Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105-3678, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9881-6731","authenticated-orcid":false,"given":"Ehsan","family":"Ullah","sequence":"additional","affiliation":[{"name":"Qatar Computing Research Institute, Hamad Bin Khalifa University, Qatar Foundation, Doha 34110, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0436-4808","authenticated-orcid":false,"given":"Nayla","family":"S. Al-Akl","sequence":"additional","affiliation":[{"name":"Diabetes Research Center, Qatar Biomedical Research Institute, Hamad Bin Khalifa University, Qatar Foundation, Doha 34110, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5060-916X","authenticated-orcid":false,"given":"Abdelilah","family":"Arredouani","sequence":"additional","affiliation":[{"name":"Diabetes Research Center, Qatar Biomedical Research Institute, Hamad Bin Khalifa University, Qatar Foundation, Doha 34110, Qatar"},{"name":"College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation, Doha 34110, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,10,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"715","DOI":"10.4254\/wjh.v9.i16.715","article-title":"Non-alcoholic fatty liver disease: An expanded review","volume":"9","author":"Benedict","year":"2017","journal-title":"World J. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Juanola, O., Mart\u00ednez-L\u00f3pez, S., Franc\u00e9s, R., and G\u00f3mez-Hurtado, I. (2021). Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph18105227"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-Alcoholic Fatty Liver Disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/TP.0000000000002484","article-title":"Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation","volume":"103","author":"Younossi","year":"2019","journal-title":"Transplantation"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Yoo, E.R., Sallam, S., Perumpail, B.J., Iqbal, U., Shah, N.D., Kwong, W., Cholankeril, G., Kim, D., and Ahmed, A. (2018). When to Initiate Weight Loss Medications in the NAFLD Population. Diseases, 6.","DOI":"10.3390\/diseases6040091"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3727\/105221617X15124844266408","article-title":"The Effects of Physical Exercise on Fatty Liver Disease","volume":"18","author":"Sud","year":"2018","journal-title":"Gene Expr."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3945\/an.116.013730","article-title":"Nutritional Approaches to Achieve Weight Loss in Nonalcoholic Fatty Liver Disease","volume":"8","author":"Hsu","year":"2017","journal-title":"Adv. Nutr. Int. Rev. J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2337\/ds017-0025","article-title":"Why Weight Loss Maintenance Is Difficult","volume":"30","author":"Evert","year":"2017","journal-title":"Diabetes Spectr."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa1105816","article-title":"Long-Term Persistence of Hormonal Adaptations to Weight Loss","volume":"365","author":"Sumithran","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/jdi.12906","article-title":"Improvement in treatment satisfaction after switching from liraglutide to dulaglutide in patients with type 2 diabetes: A randomized controlled trial","volume":"10","author":"Takase","year":"2018","journal-title":"J. Diabetes Investig."},{"key":"ref_13","first-page":"212283","article-title":"A clinical review of GLP-1 receptor agonists: Efficacy and safety in diabetes and beyond","volume":"4","author":"Isaacs","year":"2015","journal-title":"Drugs Context"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s13300-018-0560-8","article-title":"Effect of Dulaglutide Versus Liraglutide on Glucose Variability, Oxidative Stress, and Endothelial Function in Type 2 Diabetes: A Prospective Study","volume":"10","author":"Nagaike","year":"2019","journal-title":"Diabetes Ther."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"101090","DOI":"10.1016\/j.molmet.2020.101090","article-title":"Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease","volume":"46","author":"Baggio","year":"2020","journal-title":"Mol. Metab."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"600175","DOI":"10.3389\/fphar.2020.600175","article-title":"Liraglutide Alleviates Hepatic Steatosis and Liver Injury in T2MD Rats via a GLP-1R Dependent AMPK Pathway","volume":"11","author":"Zhou","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3389\/fphar.2020.00432","article-title":"Liraglutide Attenuates Non-Alcoholic Fatty Liver Disease in Mice by Regulating the Local Renin-Angiotensin System","volume":"11","author":"Yang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.3748\/wjg.v22.i8.2512","article-title":"Glucagon-like peptide-1 analogue prevents nonalcoholic steatohepatitis in non-obese mice","volume":"22","author":"Yamamoto","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.peptides.2017.11.016","article-title":"Glucagon receptor signaling in metabolic diseases","volume":"100","year":"2018","journal-title":"Peptides"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"16461","DOI":"10.1038\/s41598-018-33949-z","article-title":"Differential Effects of a Glucagon-Like Peptide 1 Receptor Agonist in Non-Alcoholic Fatty Liver Disease and in Response to Hepatectomy","volume":"8","author":"Valdecantos","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s13300-021-01072-4","article-title":"Effects of Liraglutide on Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis","volume":"12","author":"Song","year":"2021","journal-title":"Diabetes Ther."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.trsl.2020.07.008","article-title":"The GLP-1R agonist liraglutide limits hepatic lipotoxicity and inflammatory response in mice fed a methionine-choline deficient diet","volume":"227","author":"Somm","year":"2020","journal-title":"Transl. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2S28","DOI":"10.1016\/S1262-3636(17)30070-8","article-title":"Glp-1 Receptor Agonists in NAFLD","volume":"43","author":"Petit","year":"2017","journal-title":"Diabetes Metab."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Mantovani, A., Petracca, G., Beatrice, G., Csermely, A., Lonardo, A., and Targher, G. (2021). Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Trials. Metabolites, 11.","DOI":"10.3390\/metabo11020073"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1007\/s00125-020-05265-7","article-title":"Effect of dulaglutide on liver fat in patients with type 2 diabetes and NAFLD: Randomised controlled trial (D-LIFT trial)","volume":"63","author":"Kuchay","year":"2020","journal-title":"Diabetologia"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Hupa-Breier, K., Dywicki, J., Hartleben, B., Wellh\u00f6ner, F., Heidrich, B., Taubert, R., Mederacke, Y.-S., Lieber, M., Iordanidis, K., and Manns, M. (2021). Dulaglutide Alone and in Combination with Empagliflozin Attenuate Inflammatory Pathways and Microbiome Dysbiosis in a Non-Diabetic Mouse Model of NASH. Biomedicines, 9.","DOI":"10.3390\/biomedicines9040353"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.bbrc.2020.03.032","article-title":"Liraglutide Ameliorates Obesity-Related Nonalcoholic Fatty Liver Disease by Regulating Sestrin2-Mediated Nrf2\/Ho-1 Pathway","volume":"525","author":"Han","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1248\/bpb.b14-00505","article-title":"The Glucagon-Like Peptide-1 Analogue Liraglutide Inhibits Oxidative Stress and Inflammatory Response in the Liver of Rats with Diet-Induced Non-alcoholic Fatty Liver Disease","volume":"38","author":"Gao","year":"2015","journal-title":"Biol. Pharm. Bull."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/jdi.12888","article-title":"Effects of liraglutide, metformin and gliclazide on body composition in patients with both type 2 diabetes and non-alcoholic fatty liver disease: A randomized trial","volume":"10","author":"Feng","year":"2018","journal-title":"J. Diabetes Investig."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/1060028020935105","article-title":"A Systematic Review of Newer Antidiabetic Agents in the Treatment of Nonalcoholic Fatty Liver Disease","volume":"55","author":"Dougherty","year":"2020","journal-title":"Ann. Pharmacother."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1507\/endocrj.EJ16-0449","article-title":"Reduction of visceral fat by liraglutide is associated with ameliorations of hepatic steatosis, albuminuria, and micro-inflammation in type 2 diabetic patients with insulin treatment: A randomized control trial","volume":"64","author":"Bouchi","year":"2017","journal-title":"Endocr. J."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jhep.2015.08.038","article-title":"Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis","volume":"64","author":"Armstrong","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.molmet.2019.09.010","article-title":"Glucagon-Like Peptide 1 (Glp-1)","volume":"30","author":"Finan","year":"2019","journal-title":"Mol. Metab."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/s42255-020-00327-x","article-title":"Metabolic Messengers: Glucagon-like peptide 1","volume":"3","author":"Gribble","year":"2021","journal-title":"Nat. Metab."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3389\/fendo.2018.00672","article-title":"Pleiotropic Effects of Glp-1 and Analogs on Cell Signaling, Metabolism, and Function","volume":"9","author":"Rowlands","year":"2018","journal-title":"Front. Endocrinol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/B978-0-12-800101-1.00002-8","article-title":"Regulation of Glucose Homeostasis by Glp-1","volume":"121","author":"Nadkarni","year":"2014","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.cmet.2013.04.008","article-title":"Pharmacology, Physiology, and Mechanisms of Incretin Hormone Action","volume":"17","author":"Campbell","year":"2013","journal-title":"Cell Metab."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1002\/hep.23569","article-title":"Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway","volume":"51","author":"Gupta","year":"2010","journal-title":"Hepatology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s12967-021-02885-4","article-title":"Comprehensive analysis of LncRNAs expression profiles in an in vitro model of steatosis treated with Exendin-4","volume":"19","author":"Errafii","year":"2021","journal-title":"J. Transl. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1038\/s41598-022-06143-5","article-title":"Exendin-4 alleviates steatosis in an in vitro cell model by lowering FABP1 and FOXA1 expression via the Wnt\/-catenin signaling pathway","volume":"12","author":"Khalifa","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e0166913","DOI":"10.1371\/journal.pone.0166913","article-title":"Exendin-4 Inhibits Hepatic Lipogenesis by Increasing \u03b2-Catenin Signaling","volume":"11","author":"Seo","year":"2016","journal-title":"PLoS ONE"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.4081\/ejh.2020.3160","article-title":"\u03b2-catenin mediates the effect of GLP-1 receptor agonist on ameliorating hepatic steatosis induced by high fructose diet","volume":"64","author":"Gao","year":"2020","journal-title":"Eur. J. Histochem."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1038\/nprot.2014.110","article-title":"Using Fourier transform IR spectroscopy to analyze biological materials","volume":"9","author":"Baker","year":"2014","journal-title":"Nat. Protoc."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.bbamem.2006.02.011","article-title":"Applications of ATR-FTIR spectroscopic imaging to biomedical samples","volume":"1758","author":"Kazarian","year":"2006","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.1039\/C5AN00737B","article-title":"FT-IR imaging for quantitative determination of liver fat content in non-alcoholic fatty liver","volume":"140","author":"Kochan","year":"2015","journal-title":"Analyst"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/jbio.201300183","article-title":"Diagnosis of liver cancer from blood sera using FTIR microspectroscopy: A preliminary study","volume":"7","author":"Thumanu","year":"2014","journal-title":"J. Biophotonics"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1021\/cn300093g","article-title":"FTIR Imaging of Brain Tissue Reveals Crystalline Creatine Deposits Are an ex Vivo Marker of Localized Ischemia during Murine Cerebral Malaria: General Implications for Disease Neurochemistry","volume":"3","author":"Hackett","year":"2012","journal-title":"ACS Chem. Neurosci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1186\/1471-2407-10-640","article-title":"Evaluation of FTIR Spectroscopy as a diagnostic tool for lung cancer using sputum","volume":"10","author":"Lewis","year":"2010","journal-title":"BMC Cancer"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ygyno.2003.12.028","article-title":"Fourier Transform Infrared (FTIR) Spectral Mapping of the Cervical Transformation Zone, and Dysplastic Squamous Epithelium","volume":"93","author":"Wood","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/jbio.201400014","article-title":"Visualization of the biochemical markers of atherosclerotic plaque with the use of Raman, IR and AFM","volume":"7","author":"Marzec","year":"2014","journal-title":"J. Biophotonics"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.yexcr.2015.12.007","article-title":"FTIR microspectroscopy defines early drug resistant human hepatocellular carcinoma (HepG2) cells","volume":"340","author":"Junhom","year":"2016","journal-title":"Exp. Cell Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.yexcr.2016.12.027","article-title":"Partial Least Squares Regression and Fourier Transform Infrared (FTIR) Microspectroscopy for Prediction of Resistance in Hepatocellular Carcinoma Hepg2 Cells","volume":"351","author":"Junhom","year":"2017","journal-title":"Exp. Cell Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.3892\/etm.2016.3069","article-title":"Low simvastatin concentrations reduce oleic acid-induced steatosis in HepG2 cells: An in vitro model of non-alcoholic fatty liver disease","volume":"11","author":"Alkhatatbeh","year":"2016","journal-title":"Exp. Ther. Med."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Ali, M.H.M., Toor, S.M., Rakib, F., Mall, R., Ullah, E., Mroue, K., Kolatkar, P.R., Al-Saad, K., and Elkord, E. (2019). Investigation of the Effect of PD-L1 Blockade on Triple Negative Breast Cancer Cells Using Fourier Transform Infrared Spectroscopy. Vaccines, 7.","DOI":"10.3390\/vaccines7030109"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1039\/B921056C","article-title":"Resonant Mie Scattering (RMieS) correction of infrared spectra from highly scattering biological samples","volume":"135","author":"Bassan","year":"2010","journal-title":"Analyst"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"25119","DOI":"10.1007\/s11356-020-08930-x","article-title":"Recovery, physicochemical and functional characteristics of proteins from different meat processing wastewater streams","volume":"27","author":"Bethi","year":"2020","journal-title":"Environ. Sci. Pollut. Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1080\/07391102.2020.1734091","article-title":"Probing the fibrillation of lysozyme by nanoscale-infrared spectroscopy","volume":"39","author":"Islam","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1006\/abio.1994.1541","article-title":"Principal Component Analysis of Fourier Transform Infrared and\/or Circular Dichroism Spectra of Proteins Applied in a Calibration of Protein Secondary Structure","volume":"223","author":"Pribic","year":"1994","journal-title":"Anal. Biochem."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1037\/h0071325","article-title":"Analysis of a Complex of Statistical Variables into Principal Components","volume":"24","author":"Hotelling","year":"1933","journal-title":"J. Educ. Psychol."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Ali, M.H.M., Rakib, F., Nischwitz, V., Ullah, E., Mall, R., Shraim, A.M., Ahmad, M.I., Ghouri, Z.K., McNaughton, D., and K\u00fcppers, S. (2018). Application of FTIR and LA-ICPMS Spectroscopies as a Possible Approach for Biochemical Analyses of Different Rat Brain Regions. Appl. Sci., 8.","DOI":"10.3390\/app8122436"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.abb.2012.02.012","article-title":"Amifostine, a radioprotectant agent, protects rat brain tissue lipids against ionizing radiation induced damage: An FTIR microspectroscopic imaging study","volume":"520","author":"Miller","year":"2012","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1745-7270.2007.00320.x","article-title":"Fourier Transform Infrared Spectroscopic Analysis of Protein Secondary Structures","volume":"39","author":"Kong","year":"2007","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Sadat, A., and Joye, I.J. (2020). Peak Fitting Applied to Fourier Transform Infrared and Raman Spectroscopic Analysis of Proteins. Appl. Sci., 10.","DOI":"10.3390\/app10175918"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ijbiomac.2022.02.104","article-title":"Progress in Infrared Spectroscopy as an Efficient Tool for Predicting Protein Secondary Structure","volume":"206","author":"Yang","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"172618","DOI":"10.1016\/j.ejphar.2019.172618","article-title":"Pinolenic acid ameliorates oleic acid-induced lipogenesis and oxidative stress via AMPK\/SIRT1 signaling pathway in HepG2 cells","volume":"861","author":"Zhang","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Tie, F., Ding, J., Hu, N., Dong, Q., Chen, Z., and Wang, H. (2021). Kaempferol and Kaempferide Attenuate Oleic Acid-Induced Lipid Accumulation and Oxidative Stress in HepG2 Cells. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22168847"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1039\/D0FO02736G","article-title":"Hesperetin ameliorates hepatic oxidative stress and inflammation via the PI3K\/AKT-Nrf2-ARE pathway in oleic acid-induced HepG2 cells and a rat model of high-fat diet-induced NAFLD","volume":"12","author":"Li","year":"2021","journal-title":"Food Funct."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.biopha.2016.07.028","article-title":"Swertiamarin ameliorates oleic acid induced lipid accumulation and oxidative stress by attenuating gluconeogenesis and lipogenesis in hepatic steatosis","volume":"83","author":"Patel","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.biopha.2018.04.143","article-title":"Dihydrocurcumin ameliorates the lipid accumulation, oxidative stress and insulin resistance in oleic acid-induced L02 and HepG2 cells","volume":"103","author":"Yu","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/ptr.5541","article-title":"Gastrodin Ameliorates Oxidative Stress and Proinflammatory Response in Nonalcoholic Fatty Liver Disease through the AMPK\/Nrf2 Pathway","volume":"30","author":"Qu","year":"2015","journal-title":"Phytother. Res."},{"key":"ref_71","first-page":"4673","article-title":"Effects of Daphnetin on Lipid Metabolism, Insulin Resistance and Oxidative Stress in Oa-Treated Hepg2 Cells","volume":"19","author":"Liu","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1194\/jlr.M016931","article-title":"Different Fatty Acids Inhibit Apob100 Secretion by Different Pathways: Unique Roles for Er Stress, Ceramide, and Autophagy","volume":"52","author":"Caviglia","year":"2011","journal-title":"J. Lipid Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"26656","DOI":"10.1039\/C8RA02849D","article-title":"Rosmarinic acid attenuates hepatic steatosis by modulating ER stress and autophagy in oleic acid-induced HepG2 cells","volume":"8","author":"Balachander","year":"2018","journal-title":"RSC Adv."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1046\/j.1440-1746.2001.02445.x","article-title":"Lipid peroxidation in hepatic steatosis in humans is associated with hepatic fibrosis and occurs predominately in acinar zone 3","volume":"16","author":"Macdonald","year":"2001","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_75","first-page":"1237","article-title":"Exendin-4 Inhibits Lipotoxicity-Induced Oxidative Stress in \u0392-Cells by Inhibiting the Activation of Tlr4\/Nf-\u039ab Signaling Pathway","volume":"45","author":"Shen","year":"2020","journal-title":"Int. J. Mol. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1530\/JME-12-0166","article-title":"Exendin-4 Protects Endothelial Cells from Lipoapoptosis by Pka, Pi3k, Enos, P38 Mapk, and Jnk Pathways","volume":"50","author":"Erdogdu","year":"2013","journal-title":"J. Mol. Endocrinol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.jmb.2015.02.014","article-title":"Protein Quality Control under Oxidative Stress Conditions","volume":"427","author":"Dahl","year":"2015","journal-title":"J. Mol. Biol."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/10\/2652\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:58:29Z","timestamp":1760144309000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/10\/2652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,20]]},"references-count":77,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["biomedicines10102652"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines10102652","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,20]]}}}